1. Home
  2. TRMK vs DAWN Comparison

TRMK vs DAWN Comparison

Compare TRMK & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$43.22

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.50

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
DAWN
Founded
1889
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
TRMK
DAWN
Price
$43.22
$21.50
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
$44.50
$24.43
AVG Volume (30 Days)
291.3K
1.9M
Earning Date
04-28-2026
05-01-2026
Dividend Yield
2.26%
N/A
EPS Growth
1.93
N/A
EPS
0.95
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
$9.82
$55.03
Revenue Next Year
$4.86
$28.12
P/E Ratio
$45.98
N/A
Revenue Growth
N/A
20.60
52 Week Low
$33.39
$5.64
52 Week High
$45.99
$21.53

Technical Indicators

Market Signals
Indicator
TRMK
DAWN
Relative Strength Index (RSI) 40.89 80.29
Support Level $36.39 $10.30
Resistance Level $43.29 N/A
Average True Range (ATR) 0.96 0.03
MACD -0.25 -0.28
Stochastic Oscillator 8.83 90.91

Price Performance

Historical Comparison
TRMK
DAWN

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: